Hepatitis C differential diagnosis
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Hepatitis C differential diagnosis |
|
Risk calculators and risk factors for Hepatitis C differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Yazan Daaboul, Serge Korjian
Overview
Hepatitis C must be differentiated from other diseases that cause hepatic injury and abnormal liver function tests such as other viral hepatitides (Hepatitis A, Hepatitis B, and Hepatitis E) and non-viral etiologies such as alcoholic liver disease, non-alcoholic steatohepatitis, drug-induced liver injury, autoimmune hepatitis, hepatocellular carcinoma, liver abscess, pancreatitis, and bowel obstruction.
Differential Diagnosis
The differential diagnosis of hepatitis C includes other etiologies of viral hepatitis and non-viral etiologies:[1]
Viral Hepatitis Differential Diagnosis
Non-Viral Hepatitis Differential Diagnosis
- Autoimmune hepatitis
- Alcoholic liver disease
- Non-alcoholic steatohepatitis (NASH)
- Drug-induced liver injury (DILI)
- Liver abscess
- Hepatocellular carcinoma
- Cholelithiasis
- Cholecystitis
- Cholangitis
- Chronic biliary disease
- Trauma
- Abdominal aneurysm
- Gastritis
- Gastroenteritis
- Peptic ulcer disease
- Bowel obstruction
- Pancreatitis
- Pancreatic cancer
- Malignant lymphoma
- Hereditary metabolic disorders (Wilson disease, alpha-1 antitrypsin deficiency)
Differential diagnosis of jaundice as one pf symptoms of hepatitic C are: [2][3][4][5][6]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Giannini EG, Testa R, Savarino V (2005). "Liver enzyme alteration: a guide for clinicians". CMAJ. 172 (3): 367–79. doi:10.1503/cmaj.1040752. PMC 545762. PMID 15684121.
- ↑ Fargo MV, Grogan SP, Saguil A (2017). "Evaluation of Jaundice in Adults". Am Fam Physician. 95 (3): 164–168. PMID 28145671.
- ↑ Leevy CB, Koneru B, Klein KM (1997). "Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease". Gastroenterology. 113 (3): 966–72. PMID 9287990.
- ↑ Hov JR, Boberg KM, Karlsen TH (2008). "Autoantibodies in primary sclerosing cholangitis". World J. Gastroenterol. 14 (24): 3781–91. PMC 2721433. PMID 18609700.
- ↑ Bond LR, Hatty SR, Horn ME, Dick M, Meire HB, Bellingham AJ (1987). "Gall stones in sickle cell disease in the United Kingdom". Br Med J (Clin Res Ed). 295 (6592): 234–6. PMC 1247079. PMID 3115390.
- ↑ Malakouti M, Kataria A, Ali SK, Schenker S (2017). "Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?". J Clin Transl Hepatol. 5 (4): 394–403. doi:10.14218/JCTH.2017.00027. PMC 5719197. PMID 29226106.